Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2003
08/28/2003WO2002062369A3 Uroguanylin and cyclooxygenase-2 inhibitor combinations for inhibition of intestinal cancer
08/28/2003WO2002058622A3 Sn-38 lipid complexes and methods of use
08/28/2003WO2002046749A3 Screening method for identifying compounds that selectively induce interferon alpha
08/28/2003WO2002043771A3 Conjugates of glycosylated/galactosylated peptide
08/28/2003WO2002042491A3 Method for identifying compounds or lead structures against rna target motifs and rna/protein interactions
08/28/2003WO2002041880A3 Use of pyrazolo[4,3-d]pyrimidines
08/28/2003WO2002040451A3 Lactam compound
08/28/2003WO2002040032A3 Cytoprotective estrogen derivatives
08/28/2003WO2002040005A3 Blockade of sodium channels by phenol derivatives
08/28/2003WO2002036588A3 Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis
08/28/2003WO2002036149A3 Methods for obtaining inhibitors of t-cell membrane protein (tirc7) ligand binding and uses thereof
08/28/2003WO2002028430A3 Treatment of juvenile rheumatioid arthritis by oral administration of pooled human immunoglobulin and an antacid
08/28/2003WO2002015885A3 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
08/28/2003WO2002012470A3 A member of the lysyl oxidase gene family
08/28/2003WO2002005800A9 Compositions for sustained release of analgesic agents, and methods of making and using the same
08/28/2003WO2002002190A3 Prevention and treatment of neurodegenerative diseases by glutathione and phase ii detoxification enzymes
08/28/2003WO2002000638A8 Substituted phthalides as anti-convulsive drugs
08/28/2003WO2001095859A3 Novel heterocyclic analogs of diphenylethylene compounds
08/28/2003WO2001085147A3 STABILIZED FORMULATIONS OF 6-HYDROXY-3-(4-[2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL) BENZO[b]THIOPHENE AND SALTS THEREOF
08/28/2003WO2001082949A3 Method of reducing side effects of chemotherapy in cancer patients
08/28/2003WO2000042994A3 Inhibition of bacterial dissemination
08/28/2003US20030163845 Elongase genes and uses thereof
08/28/2003US20030163834 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of Erk-5
08/28/2003US20030162990 Preparation of nitrogen mustard derivatives
08/28/2003US20030162972 Pyridyl alkane acid amides as cytostatics and immunosupressives
08/28/2003US20030162969 Process and intermediates for pyridazinone antidiabetic agents
08/28/2003US20030162968 1,4-Disubstituted benzo-fused urea compounds
08/28/2003US20030162967 Having antithrombotic effect; fortherapy and prophylaxis of cardiovascular disorders like thromboembolic diseases or restenoses; reversible inhibitors of blood clotting enzymes factor Xa and/or factor VIIa
08/28/2003US20030162954 Antitumor agents; gastrointestinal disorders
08/28/2003US20030162944 Nucleic acid encoding neuropeptide Y/peptide YY (Y2) receptors and uses thereof
08/28/2003US20030162837 Carboxyfullerenes and methods of use thereof
08/28/2003US20030162836 Microbiocides
08/28/2003US20030162835 Method of making particles for use in a pharmaceutical composition
08/28/2003US20030162834 Natural physiologically active material effective on fish diseases and fish food containing the material
08/28/2003US20030162833 Fatty acid treatment for cardiac patients
08/28/2003US20030162832 L-DOPA ethyl ester salts and uses thereof
08/28/2003US20030162831 14-O-((cycloalkyl-sulfanyl)acetyl)-, 14-O-((cycloalkyl-alkyl-sulfanyl)acetyl)-, 14-O-((cycloalkoxy)acetyl)- and 14-O-((cycloalkyl-alkoxy) acetyl) mutilins; microbiocides
08/28/2003US20030162830 3,4-diphenyl-bicyclo(4.3.0)nonyl derivatives
08/28/2003US20030162829 Combination of treatment of cancer utilizing a COX-2 inhibitor and a 3-hydroxy-3-methylglutaryl-coenzyme-a (HMG-CoA) reductase inhibitor
08/28/2003US20030162828 Use of leukotriene receptor antagonist for treatment of scarring
08/28/2003US20030162827 Atorvastatin calcium and a solubilizer in a ratio of 2:2.5-10
08/28/2003US20030162826 Degradation fragments
08/28/2003US20030162825 D-amino acid oxidase inhibitors for learning and memory
08/28/2003US20030162824 Adminstering pyrazole derivatives
08/28/2003US20030162823 Novel C-4 substituted retinoids
08/28/2003US20030162821 Applying topical mixtures of allantoin, emulsifiers and optionally steroids, nonsteroidal antiinflammatory agents, leukotriene antagonists or monoclonal antibodies, to prevent scarring, ulcers or blisters on skins
08/28/2003US20030162819 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
08/28/2003US20030162817 Pentafluorobenzenesulfonamides and analogs
08/28/2003US20030162816 Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
08/28/2003US20030162814 Amines such as 2-(3-(N-hydroxyamidino)phenylamino)-N-(2'-sulfamoylbiphenyl-4-yl)-2 -methylpropionamide, used as anticoagulants or for prophylaxis of arteriosclerosis, angina pectoris, restinosis or metastasis
08/28/2003US20030162813 Heterocyclic nitrogen comppounds such as 4-(5-methyl-3-phenyl-isoxazol-1-yl)benzenesulfonamide, used as non-steroidal antiinflammatory agents or antiarthritic agents; cyclooxygenase inhibitors
08/28/2003US20030162811 Heterocyclic amines such as 4-(3'-Thienyl)-alpha, alpha, 1-trimethyl-4-piperidinemethanol and/or prodrugs, used as analgesics for prophylaxis of neuropathic pain
08/28/2003US20030162810 Topical administering of methylphenidate enantiomorphs, as anticonvulsants for the prophylaxis epilepsy, bipolar disorder or narcolepsy; side effect reduction
08/28/2003US20030162809 Use of dihydroxyquinoline to aid in increasing milk production and feed utilization
08/28/2003US20030162808 Acetindine derivatives, their preparation and medicaments containing them
08/28/2003US20030162807 Compositions and methods for treating osteoporosis and lowering cholesterol
08/28/2003US20030162806 Nitrogen compounds such as N-(4-(4- Amino-2-butyl-6,7-dimethyl -1H-imidazo(4,5-c)pyridin-1-yl)butyl)benzamide, used as immunomodulators, for inducing cytokine biosynthesis, and for prophylaxis of viral diseases
08/28/2003US20030162803 Anhydrovinblastine for the treatment of cancer
08/28/2003US20030162802 Preferential enzyme inhibitors such as 2-((4-6-pyrimidinedion -2-yl)amino)-4-methyl-5-thiazolecarboxylic acid ethyl ester, used for prophylaxis of lymphocyte associated disorders
08/28/2003US20030162801 Tricyclic compounds and their uses
08/28/2003US20030162800 Nitrogen compounds such as 10-Butyl-8-chloro-10-(trifluoro methyl)-5,10-dihydropyrimido(5,4-b)quinolin-4(3H)-one, used as polymerase inhibitors for prophylaxis of viral diseases
08/28/2003US20030162799 Squaric acid derivatives
08/28/2003US20030162798 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments
08/28/2003US20030162796 Pharmaceutical composition for the treatment of disorders of non-human mammals
08/28/2003US20030162794 Benzazole derivatives and their use as jnk modulators
08/28/2003US20030162793 Methods for preventing or treating cardiac arrhythmia
08/28/2003US20030162791 Phenylpiperazines
08/28/2003US20030162790 Benzimidazoles that are useful in treating sexual dysfunction
08/28/2003US20030162789 4-alkylpiperazine substituted phenol derivative or 4-alkylamide substituted phenols for treating neurodegerative diseases such as aging, cancer, diabetes, ischemic stroke, Parkinson's disease, dementia and Huntinton's disease
08/28/2003US20030162788 Administering to a mammal for reducing liver toxicity a heterocyclic amide compound as microsomal triglyceride transfer protein antagonist (fibrate)
08/28/2003US20030162787 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
08/28/2003US20030162786 Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein
08/28/2003US20030162784 Pyridazinone aldose reductase inhibitors
08/28/2003US20030162783 Method and composition for the treatment of pain
08/28/2003US20030162782 Treating a patient suffering from neuropathy with sidenafil, free of 5-(3-pyridyl)pyrazoleo(4,3-d)pyrimidine-7-one, 2-(3-pyridyl)-4a,5-dihydroimidazo(5,1-f)(1,2,4)triazine-4(3H)-one or 2-phenylpurine-6-one, all are substituted
08/28/2003US20030162781 A vehicle for applying insecticide or fungicide to wood containing the following components: toluene(40-70%), xylene (6-40%), benzophenone (3-18%), butyl glycol (2-9%), cetyl acetate (1-7%) and methanol (0.3- 4%); high wood penetration
08/28/2003US20030162780 Administering to a patient with a disease treatable with a muscarinic receptor antagonist a 1,2,3,4-tetrahydro-naphthalene-2-yl-alkylaminoalkyl-piperidine derivative
08/28/2003US20030162779 4-oxo-4H-thiazole derivative for treating or preventing neurodegenerative disorders
08/28/2003US20030162778 Carbocyclic side chain containing metalloprotease inhibitors
08/28/2003US20030162777 Administering a biheterocyclic compounds containing aminocarbonyl, aminothiocarbonyl or aminosulfonyl group for treating neuromuscular dysfunction of the lower urinary tract in a mammal in need of such treatment
08/28/2003US20030162776 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
08/28/2003US20030162775 Heterocyclic substituted pyrazolones
08/28/2003US20030162774 Derivatives of sulfonylurea, sulfonylthiourea, sulfonylguanidine, thioacylsufonamide and acylsulfonamide; useful for treating thromobis
08/28/2003US20030162772 For example, N-(2-(3-((1-(3,4-dichlorobenzylpiperidinyl) aminohydroxypropoxy)phenyl)acetamide; use as modulators of chemokine receptor activity, and may be used in treatment of autoimmune, inflammatory, proliferative diseases
08/28/2003US20030162771 Have an antagonistic activity with respect to corticotropin releasing factor
08/28/2003US20030162770 Use of modulators of nicotinic receptors for treatment of cognitive dysfunction
08/28/2003US20030162769 Administering suppository, containing as primary active ingredient calcium antagonist-Diltiazem Hydrochloride
08/28/2003US20030162767 Novel 1,3-dihydro-2h-indol-2-one derivatives, method for preparing same and pharmaceutical compositions containing them
08/28/2003US20030162765 Use in treatment and prevention of central nervous system and other disorders
08/28/2003US20030162764 Pyrimidine A2b selective antagonist compounds, their synthesis and use
08/28/2003US20030162763 Antibacterial agent, particularly against strains such as methicillin-resistant Staphylococcus aureus
08/28/2003US20030162762 Novel cephalosporin compounds and process for preparing the same
08/28/2003US20030162761 Androgen receptor targeting agents which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor
08/28/2003US20030162760 Dermal agent
08/28/2003US20030162759 Preventing or treating cardiovascular disease including atherosclerosis
08/28/2003US20030162758 Using regulation of pathogenic mechanisms similar to atherosclerosis; utilizing regulation of reverse cholesterol transport
08/28/2003US20030162757 Topically administering estrogen receptor antagonists
08/28/2003US20030162756 For delaying or preventing conversion of mild cognitive impairment into dementia, especially Alzheimer's Disease
08/28/2003US20030162755 Halo active aromatic sulfonamide organic compounds and uses therefor
08/28/2003US20030162754 Use of GABA and GABAB agonists
1 ... 5360 5361 5362 5363 5364 5365 5366 5367 5368 5369 5370 5371 5372 5373 5374 5375 5376 5377 5378 5379 5380 ... 7860